Document Type : Research Paper


1 Master's student / Anbar University

2 Department of Biology, College of Science, University of Anbar, Anbar,Iraq;


Pseudomonas aeruginosa is an opportunistic pathogen that causes a variety of infections throughout the world, including bacteremia in immunocompromised patients, wound and soft tissue infections, hospital-acquired pneumonia, respiratory infections, and urinary tract infections. It is also the primary cause of life-threatening infections in burn patients. A total of 120 specimens were collected from Al-Anbar Province hospitals, they were obtained from a wound (65.85%), burns (52.63), UTI (33.33%),and sputum (48.27%). Out of these specimens, 65 isolates were bacteriologically identified as P.aeruginosa depending on cultural and microscopical properties, automated (VITEK-2 system), and molecular identification based on 16SrRNA gene, which is an essential gene expressed isolates in all P.aeruginosa. The antimicrobial susceptibility test was done by using the disc diffusion method of aminoglycoside antimicrobials. The results appeared the highest resistance to Gentamycin (81.53%), Amikacin (73.84%), then Tobramycin (66.15%), and Netilmicin (33.84%). Molecular analysis of aminoglycosides modifying enzymes genes showed that the percentage of the AAC(6 ′ )-Ib gene was highest 16/20 (85%), then 8/20 (40%), 2/20 (10%) for ANT (3 ″ )-Ia , APH(3 ′ )-IIb, respectively.


Main Subjects

[1]Dou Y, Huan J, Guo F, Zhou Z, Shi Y. Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014. J Int Med Res. 2017;45(3):1124–37.
 [ 2]      Liew SM, Rajasekaram G, Puthucheary SDA, Chua KH. Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of Pseudomonas aeruginosa. PeerJ. 2019;7:e6217.
[ 3]Darby EM, Trampari E, Siasat P, Gaya MS, Alav I, Webber MA, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2022;1–16.
 [ 4]      Breidenstein EBM, de la Fuente-Núñez C, Hancock REW. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 2011;19(8):419–26.
[5]Thacharodi A. The genetic basis of aminoglycoside resistance in Pseudomonas aeruginosa. University of Otago; 2022.
 [6] Amoon RH, Abdallha AH, Sharif AO, Moglad EH, Altyb HN, Elzaki SG, et al. Molecular characterization of Pseudomonas aeruginosa isolates from Sudanese patients: A cross-sectional study. F1000Research. 2018;7(1135):1135.
[ 7] Ahmadian L, Norouzi Bazgir Z, Ahanjan M, Valadan R, Goli HR. Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran. Biomed Res Int. 2021;2021.
[8]Al-Luhaiby HAK. No TitleMolecular Study on Quorum System Genes and it’s correlated with some Virulence Factors in Pseudomonas aeruginosa. Anbar; 2022.
[ 9] Kamali E, Jamali A, Ardebili A, Ezadi F, Mohebbi A. Evaluation of antimicrobial resistance, biofilm forming potential, and the presence of biofilm-related genes among clinical isolates of Pseudomonas aeruginosa. BMC Res Notes. 2020;13:1–6.
 [10]Karami P, Mohajeri P, Mashouf RY, Karami M, Yaghoobi MH, Dastan D, et al. Molecular characterization of clinical and environmental Pseudomonas aeruginosa isolated in a burn center. Saudi J Biol Sci. 2019;26(7):1731–6.
[11] Motbainor H, Bereded F, Mulu W. Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study. BMC Infect Dis. 2020;20:1–11.
 [12] Issa MAS, Ghaima KK, Saleh MB, Nader MI. Antibiogram study and prevalence of pslá gene among biofilm Pseudomonas aeruginosa producers isolated from some clinical specimens in thi_qar province. Pakistan J Biotechnol. 2018;15(3):681–8.
 [13] Li Y, Ren L, Zou J. Risk factors and prevention strategies of nosocomial infection in geriatric patients. Can J Infect Dis Med Microbiol. 2019;2019.
 [ 14] Fattah RAFA, Mohamed TAH, Elsayed MS. Effect of chitosan nanoparticles on quorum sensing-controlled virulence factors and expression of LasI and RhlI genes among Pseudomonas aeruginosa clinical isolates. AIMS Microbiol. 2021;7(4):415.
 [15] van Burgh S, Maghdid DM, Ganjo AR, Mansoor IY, Kok DJ, Fatah MH, et al. PME and other ESBL-positive multiresistant Pseudomonas aeruginosa isolated from hospitalized patients in the region of Kurdistan, Iraq. Microb Drug Resist. 2019;25(1):32–8.
 [ 16]Attiah SA, Majeed GH, Mohammed TK. Molecular detection of the exoU and toxA genes among Pseudomonas aeruginosa of patients with burn and wound infection in Baghdad City. Ann Rom Soc Cell Biol. 2021;25(6):109–22.
 [17]AL-Kaisse AA, AL-Thwani AN, AL-Segar AN. Incidence and Antibiotics Sensitivity of Multidrug-Resistance of Pseudomonas aeruginosa Isolated from Burn’s Patients and Environmental Samples fromThree Hospitals in Baghdad. J Biotechnol Res Cent. 2015;9(2):67–73.
 [18]Abdel FR, Abbas MK, Jaafar FN, Mukhlif M. Detection of Genome Content of Pseudomonas Aeruginosa Biofilm Formation and Resistance to Some Disinfectants and Antibiotics. Eng Technol J. 2016;34(1 Part (B) Scientific).
 [ 19]Alsaadi LA. Molecular Detection of Multidrug Resistant of Some Genes and the Effect of ZnONPs as Alternative to Antibiotics for Pseudomonas aeruginosa. Dr Philos Biol Coll Educ Pure Sci Dep Biol Univ Diyala. 2020;
 [ 20]    Aljanaby AAJ, Aljanaby IAJ. Prevalence of aerobic pathogenic bacteria isolated from patients with burn infection and their antimicrobial susceptibility patterns in Al-Najaf City, Iraq-a three-year cross-sectional study. F1000Research. 2018;7(1157):1157.
 [21]Abdul-Wahid AA. Dissemination of Aminoglycosides resistance in Pseudomonas aeruginosa isolates in Al-Nasseryia hospitals. M. Sc. Thesis. College of Medicine. University of Kufa; 2014.
 [22]Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, et al. Role of efflux pumps: MexAB-OprM and MexXY (-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients. Infect Genet Evol. 2014;24:187–92.
 [23] Farhan SM, Raafat M, Abourehab MAS, El-Baky RMA, Abdalla S, El-Gendy AO, et al. Effect of Imipenem and Amikacin Combination against Multi-Drug Resistant Pseudomonas aeruginosa. Antibiotics. 2021;10(11):1429.
 [24] Panahi T, Asadpour L, Ranji N. Distribution of aminoglycoside resistance genes in clinical isolates of Pseudomonas aeruginosa in north of Iran. Gene Reports. 2020 Dec 1;21:100929.
[25]El-Badawy MF, Alrobaian MM, Shohayeb MM, Abdelwahab SF. Investigation of six plasmid-mediated quinolone resistance genes among clinical isolates of pseudomonas: a genotypic study in Saudi Arabia. Infect Drug Resist. 2019;915–23.
 [ 26] Kashfi M, Hashemi A, Eslami G, Amin MS, Tarashi S, Taki E. The prevalence of aminoglycoside-modifying enzyme genes among Pseudomonas aeruginosa strains isolated from burn patients. Arch Clin Infect Dis. 2017;12(1).
[ 27]     Brackman G, Cos P, Maes L, Nelis HJ, Coenye T. Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother. 2011;55(6):2655–61.
 [ 28] Martí S, Bastida A, Swiderek K. Theoretical Studies on Mechanism of Inactivation 4′-O-Nucleotidyltransferase of Kanamycin A by. Challenges Comput Enzymol. 2019;